1 |
The Federation of Pharmaceutical Manufacturers' Associations of Japan. Regarding Revision of the General Kampo Drugs Approval Criteria. 2012. from www.sigayaku.jp/pdf2/20120903/nitiyaku496.pdf.
|
2 |
Korea Institute for Defense Analyses. World War Watch. Retrieved Aug. 1, 2015, from http://www.kida.re.kr/woww/dispute_detail.asp?idx=106.
|
3 |
Sun Ten Pharmaceutical Co., Ltd. Pharmaceutical Company Official Website. Retrieved July 30, 2015, from http://www.suntenglobal.com/about/index.php
|
4 |
Kim TW, Han CH. Medicine within Society, Society within Medicine: An Anthropological Exploration of Korean Medicine in South Korea and Traditional Chinese Medicine in China. J Korean Orient Intern Med. 2012 ; 33(2) : 111-25.
DOI
|
5 |
Kim JS, Lee SW, Kim YK. A Study about Policy Regime for the Protection of the Rights of Korean Traditional Medicine in the World Market. J Law Pol Res. 2014 ; 14(1) : 16-21.
|
6 |
Kook YB, Kim SC, Park SD, Park SK, Seo BI, Seo YB, et al. Korean Science of Prescription. Seoul : Yeongnim Publishing Company. 2009 : 65-612.
|
7 |
Doosan Corporation Doopedia. The Explanation of Shanghan Lun. Retrieved July 31, 2015, from http://www.doopedia.co.kr/doopedia/master/master.do?_method=view&MAS_IDX=101013000740847
|
8 |
Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China 2010 edition. 2010 : 1249-65.
|
9 |
National Standard for People's Republic of China. Chinese Classification of Name and Code for Disease and Syndrome. Retrieved Aug. 3, 2015, from http://wenku.baidu.com/link?url=-UaWvz8J8ont5O3n68SopRkH8aw5UyqGr_sZcno41AEy1bTh_LyL9tZOu1I8AmGRdJBUQcpiGiz2sNkifikWksw8XI1gUuGjmTS3M_yg_pS
|
10 |
Choi SM, Shin HK, Shin MK. The research on the disease classifications of the traditional medicine in China, Japan, Taiwan, and North Korea. Korean J Orient Med. 1999 ; 5(1) : 81-100.
|
11 |
Tetsuo A. History of Kampo Extracts for Medical Use. Kampo Med. 2010 ; 61(7) : 881-8.
DOI
|
12 |
Hanpoong Pharm & Foods Co., Ltd. History of Hanpoong Pharm & Foods Co. Hanpoong Pharm & Foods Co. Official Website. Retrieved Aug. 2, 2015, from http://www.hanpoong.co.kr/ab-1355
|
13 |
Kim CH. Interview for Company of Reimbursement Herbal Medicine, (1) Hanpoog Pharmaceutical. The Minjok Medicine News, 2013.7.11. Retrieved Aug. 2, 2015, from http://www.mjmedi.com/news/articleView.html?idxno=25461
|
14 |
Ministry Food and Drug Safety. The Korean Herbal Pharmacopoeia 4th Edition. Notification 2012. 2012 : 1.
|
15 |
Park SJ, Kim IR. The Comparative Study on Zanthoxylum Peel's Impurity Tolerance Based on Pharmacopoeia by Countries. Kor J Herbol. 2010 ; 25(1) : 45-54.
|
16 |
Kim YW. A Comparative Study on Herb Medicines Listed in the Pharmacopeia of Korea, China and Japan. Doctoral Dissertation. Graduate School of Wonkwang University. 2008.
|
17 |
Ministry of Health and Welfare. Taiwan Herbal Pharmacopoeia Second Edition. 2013 : 85-106.
|
18 |
Han BH. The International Harmonization Policy Trend of Herbal Medicines standards – Focusing on FHH(Forum on Harmonization of Herbal Medicines) - : KHIDI(Korea Health Industry Development Institute). 2002 : 122-126. from http://www.khidi.or.kr/board/view?linkId=101176&menuId=MENU00090.
|
19 |
Ministry Food and Drug Safety. The Korean Pharmacopoeia 11th edition. Notification No. 2014.
|
20 |
Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China 2010 edition. 2010 : 399-1248.
|
21 |
Ministry of Health, Labour and Welfare. The Japanese Pharmacopoeia 16th edition. The Ministry of Health, Labour and Welfare Ministerial Notification 2011. 2011 : 289-1604.
|
22 |
Drugs in Japan Forum. Drugs In Japan Ethical Drugs. Tokyo : Time Signal Publishing Company. 2007 : 853-1128.
|
23 |
Ministry of Food and Drug Safety. The Korean Herbal Pharmacopoeia 4th edition. The MFDS Notification 2012. 2012 : 11-592.
|
24 |
Shin SS, Kim DC, Kim SJ, Jung DC, Ryu CR, Sung HJ. The Comparison Research on Oriental Medicinal Materials of Asian Nation Pharmacopoeias. J Assoc Neo Med. 2000 ; 5(2) : 267-76.
|